1. Home
  2. ABEV vs KVUE Comparison

ABEV vs KVUE Comparison

Compare ABEV & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambev S.A.

ABEV

Ambev S.A.

HOLD

Current Price

$2.81

Market Cap

43.4B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.53

Market Cap

34.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEV
KVUE
Founded
1885
2022
Country
Brazil
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Specialty Chemicals
Sector
Consumer Staples
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
43.4B
34.9B
IPO Year
2012
2023

Fundamental Metrics

Financial Performance
Metric
ABEV
KVUE
Price
$2.81
$17.53
Analyst Decision
Hold
Buy
Analyst Count
4
11
Target Price
$2.69
$19.73
AVG Volume (30 Days)
21.9M
22.7M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
6.80%
4.72%
EPS Growth
N/A
40.74
EPS
N/A
0.76
Revenue
N/A
$15,124,000,000.00
Revenue This Year
$7.85
$4.82
Revenue Next Year
$5.23
$2.61
P/E Ratio
$16.99
$23.12
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$14.02
52 Week High
$3.24
$25.17

Technical Indicators

Market Signals
Indicator
ABEV
KVUE
Relative Strength Index (RSI) 42.74 41.25
Support Level $2.70 $17.13
Resistance Level $3.24 $17.52
Average True Range (ATR) 0.07 0.26
MACD -0.01 -0.03
Stochastic Oscillator 27.03 20.99

Price Performance

Historical Comparison
ABEV
KVUE

About ABEV Ambev S.A.

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: